Total Payments
$543,713
2024 Payments
$53,806
Companies
12
Transactions
399
Medicare Patients
15,166
Medicare Billing
$9.4M
Payment Breakdown by Category
Other$377,346 (69.4%)
Consulting$99,804 (18.4%)
Travel$55,902 (10.3%)
Food & Beverage$10,662 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $356,346 | 84 | 65.5% |
| Consulting Fee | $99,804 | 14 | 18.4% |
| Travel and Lodging | $55,902 | 109 | 10.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $15,000 | 1 | 2.8% |
| Food and Beverage | $10,662 | 187 | 2.0% |
| Honoraria | $6,000 | 4 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $192,071 | 172 | $0 (2024) |
| Genentech USA, Inc. | $186,521 | 155 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $61,056 | 11 | $0 (2019) |
| Apellis Pharmaceuticals, Inc. | $48,975 | 38 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $41,210 | 7 | $0 (2017) |
| Genentech, Inc. | $7,850 | 1 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $5,708 | 7 | $0 (2021) |
| TOPCON MEDICAL SYSTEMS, INC. | $223.79 | 4 | $0 (2017) |
| Abbott Laboratories | $34.27 | 1 | $0 (2018) |
| Amgen Inc. | $27.02 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53,806 | 43 | Regeneron Healthcare Solutions, Inc. ($26,281) |
| 2023 | $135,998 | 89 | Regeneron Healthcare Solutions, Inc. ($63,247) |
| 2022 | $98,495 | 106 | Regeneron Healthcare Solutions, Inc. ($51,304) |
| 2021 | $40,596 | 40 | Regeneron Healthcare Solutions, Inc. ($33,192) |
| 2020 | $28,216 | 22 | Regeneron Healthcare Solutions, Inc. ($17,907) |
| 2019 | $22,857 | 17 | Bausch & Lomb, a division of Bausch Health US, LLC ($13,532) |
| 2018 | $81,432 | 34 | Bausch & Lomb, a division of Bausch Health US, LLC ($47,524) |
| 2017 | $82,313 | 48 | Valeant Pharmaceuticals North America LLC ($41,210) |
All Payment Transactions
399 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,640.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,582.33 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/06/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $124.37 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/21/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,720.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,640.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $1,004.01 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $121.85 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/15/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/16/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Ophthalmology | ||||||
| 10/08/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Travel and Lodging | In-kind items and services | $974.38 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/08/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $82.78 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Travel and Lodging | In-kind items and services | $40.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/05/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/20/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/16/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Ophthalmology | ||||||
| 08/16/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: Ophthalmology | ||||||
| 08/16/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $0.61 | General |
| Category: Ophthalmology | ||||||
| 06/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/07/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $34.02 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/14/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,646.00 | General |
| Category: Ophthalmology | ||||||
| 05/14/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Ophthalmology | ||||||
| 05/09/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/09/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Travel and Lodging | In-kind items and services | $721.94 | General |
| Category: Immunology and Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 3,943 | 32,577 | $3.4M | $2.1M |
| 2022 | 15 | 4,350 | 16,075 | $3.7M | $2.6M |
| 2021 | 14 | 3,776 | 13,134 | $3.3M | $2.5M |
| 2020 | 12 | 3,097 | 11,104 | $3.0M | $2.2M |
Total Patients
15,166
Total Services
72,890
Medicare Billing
$9.4M
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 81 | 22,260 | $838,072 | $648,219 | 77.3% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 96 | 830 | $750,369 | $576,125 | 76.8% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 91 | 2,419 | $623,666 | $437,171 | 70.1% |
| 67028 | Injection of drug into eye | Office | 2023 | 256 | 1,035 | $511,395 | $117,089 | 22.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 556 | 1,509 | $196,505 | $115,369 | 58.7% |
| 92134 | Imaging of retina | Office | 2023 | 1,016 | 2,323 | $144,892 | $79,210 | 54.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 581 | 706 | $118,293 | $72,119 | 61.0% |
| 92250 | Photography of the retina | Office | 2023 | 810 | 998 | $62,522 | $32,370 | 51.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 240 | 240 | $109,158 | $27,881 | 25.5% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 43 | 56 | $17,762 | $8,384 | 47.2% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 93 | 119 | $13,680 | $5,443 | 39.8% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 27 | 27 | $4,602 | $3,086 | 67.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 37 | 39 | $3,641 | $2,115 | 58.1% |
| 92285 | Photography of content of eyes | Office | 2023 | 16 | 16 | $2,600 | $332.10 | 12.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 129 | 1,421 | $1.3M | $1.0M | 76.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 123 | 3,579 | $1.2M | $788,007 | 64.9% |
| J3590 | Unclassified biologics | Office | 2022 | 23 | 96 | $208,675 | $147,307 | 70.6% |
| 67028 | Injection of drug into eye | Office | 2022 | 263 | 1,243 | $212,380 | $139,038 | 65.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 530 | 1,679 | $197,647 | $135,079 | 68.3% |
| 92134 | Imaging of retina | Office | 2022 | 973 | 2,593 | $139,906 | $93,212 | 66.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 589 | 738 | $124,808 | $76,492 | 61.3% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 21 | 2,340 | $95,706 | $69,829 | 73.0% |
| 92250 | Photography of the retina | Office | 2022 | 801 | 1,064 | $77,543 | $35,604 | 45.9% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 224 | 224 | $51,360 | $28,309 | 55.1% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 154 | 218 | $19,652 | $10,182 | 51.8% |
About Dr. Michael Cooney, MD
Dr. Michael Cooney, MD is a Specialist healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073548434.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Cooney, MD has received a total of $543,713 in payments from pharmaceutical and medical device companies, with $53,806 received in 2024. These payments were reported across 399 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($356,346).
As a Medicare-enrolled provider, Cooney has provided services to 15,166 Medicare beneficiaries, totaling 72,890 services with total Medicare billing of $9.4M. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Ophthalmology
- Location New York, NY
- Active Since 07/12/2006
- Last Updated 01/23/2020
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1073548434
Products in Payments
- EYLEA (Biological) $115,366
- Lucentis (Biological) $88,219
- EYLEA HD (Biological) $76,565
- Vabysmo (Drug) $64,695
- VABYSMO (Drug) $33,572
- Syfovre (Drug) $29,393
- BROLUCIZUMAB (Drug) $3,430
- BEOVU (Drug) $2,278
- DRI-OCT TRITON (Device) $223.79
- EYLEA AFLIBERCEPT INJECTION (Biological) $140.83
- PROLENSA (Drug) $108.07
- Epic Stented Tissue Valve (Device) $34.27
- TEPEZZA (Biological) $27.02
- VISUDYNE (Drug) $23.71
- IYUZEH (Drug) $15.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in New York
Dr. Eric Rose, M.d, M.D
Specialist — Payments: $4.9M
Specialist $4.9M
Dr. Baron Lonner, M.d, M.D
Specialist — Payments: $2.9M
Specialist $2.9M
Dr. Richard Spaide, Md, MD
Specialist — Payments: $1.7M
Specialist $1.7M
Dr. Marla Dubinsky, M.d, M.D
Specialist — Payments: $1.6M
Specialist $1.6M
Mrs. Naomi Nakao, M.d, M.D
Specialist — Payments: $1.1M
Specialist $1.1M
Dr. Janice Dutcher, M.d, M.D
Specialist — Payments: $994,054
Specialist $994,054